CTRI/2015/08/006092已完成4 期
An open label, prospective, comparative, multicentre, 2 weeks study to assess the device handling, human factors, ease of use, errors and participant perception on use of a breath actuated inhaler versus pressurized metered dose inhaler in healthy volunteers and in patients with Asthma or COPD.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Cipla Ltd
- 入组人数
- 460
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. A written signed dated informed consent from all participants before study procedures.
- •2. Participants of both genders either healthy or confirmed diagnosis with Asthma (updated GINA 2015) aged between 5 and 80 years or confirmed diagnosis with COPD (updated GOLD 2015)aged between 40 to 80 years.
- •3. Patients using only pMDI device over past 3 months.
排除标准
- •1. Current or past users of breath actuated inhaler
研究者
相似试验
已完成
3 期
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX, in subjects >= 70 years of ageShingles10047438Herpes ZosterNL-OMON31421Sanofi Pasteur MSD S.N.C.150
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 2-dose regimen of ProQuad® manufactured with rHA administered to healthy children from 9 months of ageMeasles, mumps, rubella and varicella vaccine administered to healthy children from 9 months of ageEUCTR2007-002468-88-FISanofi Pasteur MSD SNC1,620
进行中（未招募）
1 期
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX ®, in subjects = 70 years of ageEUCTR2007-000744-28-NLSanofi Pasteur MSD S.N.C.
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 2-dose regimen of ProQuad® manufactured with rHA administered to healthy children from 9 months of ageMeasles, mumps, rubella and varicella vaccine administered to healthy children from 9 months of ageEUCTR2007-002468-88-DESanofi Pasteur MSD SNC1,620
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX , in subjects equal or over 70 years of age - NDEUCTR2007-000744-28-ITSanofi Pasteur MSD S.N.C.750